Drug profile · INN
allopurinol sodium
ALLOPURINOL SODIUM
allopurinol sodium (ALLOPURINOL SODIUM) is a xanthine dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — allopurinol sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
allopurinol sodium (ALLOPURINOL SODIUM) is a xanthine dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Xanthine dehydrogenase inhibitor
Primary target: Xanthine dehydrogenase/oxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is allopurinol sodium?
allopurinol sodium (ALLOPURINOL SODIUM) is a xanthine dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for allopurinol sodium?
ALLOPURINOL SODIUM is a marketed brand name for allopurinol sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of allopurinol sodium?
allopurinol sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.